XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Condensed Statements Of Cash Flows
$ in Thousands, SFr in Millions
3 Months Ended 12 Months Ended
Oct. 31, 2023
USD ($)
Oct. 31, 2022
USD ($)
Jul. 31, 2023
USD ($)
Statement of Cash Flows [Abstract]      
Net loss $ (183,047) $ (143,560)  
Cash flows from operating activities:      
Depreciation and amortization 66,728 64,614  
Stock-based compensation expense 6,796 6,345  
Benefit from income taxes (65,160) (58,006)  
Other non-cash expense 8,217 8,615  
Changes in assets and liabilities:      
Trade receivables, net 272,313 264,285  
Inventories, net (26,789) (31,924)  
Accounts payable and accrued liabilities (773) 2,508  
Deferred revenue 308,950 279,221  
Income taxes payable (17,052) (20,460)  
Other assets and liabilities, net (41,684) (38,647)  
Net cash provided by operating activities 328,499 332,991  
Cash flows from investing activities:      
Capital expenditures (53,379) (124,099)  
Return of deposit for acquisition of business 0 114,506 $ (114,400)
Acquisition of business, net of cash acquired 0 (38,567)  
Investments in short-term deposits 0 (86,756)  
Maturity of short-term deposits 52,437 0  
Other investing activities, net 6,507 385  
Net cash provided by (used in) investing activities 5,565 (134,531)  
Cash flows from financing activities:      
Repayments of borrowings under Vail Holdings Credit Agreement (15,625) (15,625)  
Employee taxes paid for share award exercises (5,195) (4,043)  
Dividends paid (78,471) (77,018)  
Repurchases of common stock (50,000) 0  
Other financing activities, net (4,317) (7,942)  
Net cash used in financing activities (153,608) (104,628)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (13,158) (18,876)  
Net increase in cash, cash equivalents and restricted cash 167,298 74,956  
Cash, Cash Equivalents and Restricted Cash:      
Beginning of period 573,093 1,126,107 1,126,107
End of period 740,391 1,201,063 $ 573,093
Accrued capital expenditures $ 38,275 $ 21,069